Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 4
2017 5
2018 3
2019 14
2020 21
2021 22
2022 13
2023 14
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis.
Menz BD, Kuderer NM, Bacchi S, Modi ND, Chin-Yee B, Hu T, Rickard C, Haseloff M, Vitry A, McKinnon RA, Kichenadasse G, Rowland A, Sorich MJ, Hopkins AM. Menz BD, et al. Among authors: hopkins am. BMJ. 2024 Mar 20;384:e078538. doi: 10.1136/bmj-2023-078538. BMJ. 2024. PMID: 38508682 Free PMC article.
Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system.
Tang J, Lam GT, Brooks RD, Miles M, Useckaite Z, Johnson IR, Ung BS, Martini C, Karageorgos L, Hickey SM, Selemidis S, Hopkins AM, Rowland A, Vather R, O'Leary JJ, Brooks DA, Caruso MC, Logan JM. Tang J, et al. Among authors: hopkins am. Cancer Lett. 2024 Mar 31;585:216639. doi: 10.1016/j.canlet.2024.216639. Epub 2024 Jan 28. Cancer Lett. 2024. PMID: 38290660 Free article. Review.
Association of proton pump inhibitor use with survival and adverse effects outcomes in patients with multiple myeloma: pooled analysis of three clinical trials.
Almansour SA, Alqudah MAY, Abuhelwa Z, Al-Shamsi HO, Semreen MH, Bustanji Y, Soare NC, McKinnon RA, Sorich MJ, Hopkins AM, Abuhelwa AY. Almansour SA, et al. Among authors: hopkins am. Sci Rep. 2024 Jan 5;14(1):591. doi: 10.1038/s41598-023-48640-1. Sci Rep. 2024. PMID: 38182614 Free PMC article. Clinical Trial.
Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies.
Shahnam A, Hitchen N, Nindra U, Manoharan S, Desai J, Tran B, Solomon B, Luen SJ, Hui R, Hopkins AM, Sorich MJ. Shahnam A, et al. Among authors: hopkins am. Eur J Cancer. 2024 Feb;198:113503. doi: 10.1016/j.ejca.2023.113503. Epub 2023 Dec 18. Eur J Cancer. 2024. PMID: 38134560
97 results